文献速递复苏、休克与脓毒症

腺苷、利多卡因与镁离子液体治疗使失血性休克后72小时存活:研究差异基因表达与延长生物学时间的模型

Adenosine, lidocaine, and Mg2+ fluid therapy leads to 72-hour survival after hemorrhagic shock: A model for studying differential gene expression and extending biological time.
PubMed 文献 · J Trauma Acute Care Surg · 2019-01-01
一句话结论大鼠非控制性失血性休克模型中,小容量ALM治疗使平均存活时间达72小时,较生理盐水对照的22.6小时延长3.3倍。

该研究在Sprague-Dawley大鼠肝切除诱导的非控制性失血性休克模型中,比较3% NaCl腺苷、利多卡因与镁(ALM)团注加0.9% NaCl/ALM持续滴注与生理盐水对照的72小时存活及心、脑、肝关键代谢基因表达。ALM组平均存活时间为72±0小时,对照组为22.6±4.5小时(p<0.05),对照组死亡时乳酸升高约7倍而ALM组维持基线水平。ALM组心、脑amp-k、PGC-1α、sirt-1表达较对照高1.5倍和2.7倍,心脏mtCO3高19倍,但肝脏amp-k、sirt-1、mtCO3低29-41%、PGC-1α低75%。作者认为心脑基因上调可能增强线粒体功能与ATP产生,而肝脏呈相反下调,这些中枢-外周差异需进一步研究。

要点

  • 大鼠肝切除非控制性失血性休克模型中,ALM组平均存活72±0小时 vs 生理盐水对照22.6±4.5小时(p<0.05),延长3.3倍。
  • 对照组死亡时乳酸升高约7倍,ALM组72小时内乳酸维持与基线相似。
  • ALM组心、脑amp-k、PGC-1α、sirt-1表达较对照高1.5倍和2.7倍(p<0.05),心脏mtCO3高19倍。
  • ALM组肝脏amp-k、sirt-1、mtCO3表达较对照低29-41%,PGC-1α低75%。
  • ALM方案为大鼠静脉团注0.7 mL/kg 3% NaCl±ALM,60分钟后0.9% NaCl±ALM以0.5 mL/kg/h滴注4小时。

适用人群与场景

  • 雄性Sprague-Dawley大鼠(425±8 g),肝切除(60%左外侧叶)诱导的非控制性失血性休克模型。

处置流程与药物剂量

  • 第一阶段:出血后15分钟静脉团注3% NaCl±ALM 0.7 mL/kg。
  • 第二阶段:出血后60分钟开始0.9% NaCl±ALM以0.5 mL/kg/h滴注4小时,随后监测72小时。

研究设计与关键结果

  • 研究类型:大鼠非控制性失血性休克模型,生理盐水对照(n=10)vs ALM治疗(n=10)。
  • 主要终点:Kaplan-Meier存活曲线示对照组平均存活22.6±4.5小时,ALM组72±0小时(p<0.05),延长3.3倍。
  • 对照组死亡时乳酸升高约7倍,ALM组72小时内乳酸维持与基线相似。
  • ALM组心、脑amp-k、PGC-1α、sirt-1表达较对照高1.5倍和2.7倍(p<0.05),心脏mtCO3高19倍。
  • ALM组肝脏amp-k、sirt-1、mtCO3表达较对照低29-41%,PGC-1α低75%。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为小容量ALM治疗在失血性休克后使存活时间较生理盐水对照延长3.3倍,心脑amp-k、PGC-1α、sirt-1、mtCO3上调可能增强线粒体功能与ATP产生,肝脏呈相反下调;心脑与肝脏的基因表达差异需进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Noncompressible torso hemorrhage is a leading cause of traumatic death. Our aim was to examine survival time and the expression of key master genes of cellular metabolism after 3% NaCl adenosine, lidocaine, and Mg (ALM) bolus and 4 hours 0.9% NaCl/ALM "drip" in a rat model of uncontrolled hemorrhagic shock.

METHODS: Male Sprague-Dawley rats (425 ± 8 g) were anesthetized and randomly assigned to saline controls (n = 10) or ALM therapy (n = 10). Hemorrhage was induced by liver resection (60% left lateral lobe). After 15 minutes, a single intravenous bolus of 3% NaCl ± ALM (0.7 mL/kg) was administered (Phase 1), and after 60 minutes, a 0.9% NaCl ± ALM stabilization "drip" (0.5 mL/kg per hour) was infused for 4 hours (Phase 2) with 72 hours monitoring. Mean arterial pressure and lactate were measured. After 72 hours (or high moribund score), tissues were freeze-clamped and stored at -80°C. Total RNA was extracted in heart, brain, and liver, and the relative expressions of amp-k, mtCO3, PGC-1α, and sirt-1 genes were determined.

RESULTS: Kaplan-Meier survival curves showed that controls had a mean survival time of 22.6 ± 4.5 hours, and ALM animals, 72 ± 0 hours (p < 0.05). Death in controls was accompanied by approximately sevenfold increase in lactate, while ALM animals maintained lactates similar to baseline over 72 hours. The relative expression of amp-k, PGC-1α, and sirt-1 in heart and brain was 1.5-fold and 2.7-fold higher in the ALM group compared with controls (p < 0.05), with the exception of mitochondrial encoded cytochrome C oxidase III pseudogene 1 in heart, which was 19-fold higher. In contrast, amp-k, sirt-1, and mtCO3 gene expression in liver was significantly 29-41% lower in the ALM group compared with controls, and PGC-1α was 75% lower.

CONCLUSION: Small-volume ALM therapy led to 3.3-times longer survival time compared with saline controls after hemorrhagic shock. A hallmark of the ALM-survival phenotype in heart and brain was an upregulation of amp-k, PGC-1α, sirt-1, and mtCO3 to presumably "boost" mitochondrial function and ATP production, and a contrasting downregulation in liver. These central-peripheral differences in gene expression require further investigation.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Letson HL, Morris JL, Biros E, et al. Adenosine, lidocaine, and Mg2+ fluid therapy leads to 72-hour survival after hemorrhagic shock: A model for studying differential gene expression and extending biological time. J Trauma Acute Care Surg. 2019. PMID: 31162330. doi:10.1097/TA.0000000000002397

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。